161 related articles for article (PubMed ID: 35594161)
21. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
[TBL] [Abstract][Full Text] [Related]
23. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
[TBL] [Abstract][Full Text] [Related]
25. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
26. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.
Chak E; Saab S
Liver Int; 2010 Oct; 30(9):1247-58. PubMed ID: 20602682
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of de novo cancer in liver transplant recipients.
Riis TH; Møller DL; Høgh J; Knudsen AD; Rostved AA; Akdag D; Kirkby N; Lassen U; Rasmussen A; Hillingsø JG; Pommergaard HC
APMIS; 2023 Apr; 131(4):135-141. PubMed ID: 36680559
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
[TBL] [Abstract][Full Text] [Related]
31. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
[TBL] [Abstract][Full Text] [Related]
32. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
[TBL] [Abstract][Full Text] [Related]
34. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
[TBL] [Abstract][Full Text] [Related]
35. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
[TBL] [Abstract][Full Text] [Related]
36. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
38. De novo malignancy in heart transplant recipients: A single center experience in Japan.
Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
[TBL] [Abstract][Full Text] [Related]
39. Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients With Nonalcoholic Steatohepatitis.
Dutta N; Marka N; Lake J; Lim N
Transplant Proc; 2023 Nov; 55(9):2023-2026. PubMed ID: 37730450
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
